Moximed
Company

Last deal

$61M

Amount

Series D

Stage

13.08.2024

Date

9

all rounds

$204.2M

Total amount

General

About Company
Moximed develops implants for knee osteoarthritis patients, reducing joint pain and improving mobility.

Industry

Sector :

Subsector :

Also Known As

MISHA, ExploraMed NC4

founded date

01.01.2006

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

Moximed is a California-based company founded in 2006 that specializes in developing unicompartmental load absorber implants for patients with knee osteoarthritis. Their implants provide a non-invasive treatment option that absorbs excess joint load, minimizing pain and allowing patients to regain normal activity levels. Unlike traditional procedures, Moximed's implants do not require bone cutting or removal, offering a more patient-friendly approach to managing osteoarthritis. By slowing disease progression and restoring joint function, Moximed aims to improve the standard of care for osteoarthritis patients.
Contacts

Social url